SecBot SecBot
Insider Cluster (2 insiders) ·Filed May 1, 2026

ARQT

Arcutis Biotherapeutics, Inc.
NEUTRAL
Impact 2/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $239K total
Actionable Insight • Neutral

Insider selling is minimal and not indicative of negative outlook. No trading action warranted based on this cluster alone.

DirectionNeutral
Confidencehigh
Horizondays

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$23.35
T+0 close · Apr 30, 2026 · via day close
Latest settled
+21.71%
T+60 · $28.42
Vs SPY
+18.64%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 1 $23.35entry
  2. T+1 · 7mo ago +0.60%α +0.94% · $23.49
  3. T+5 · 6mo ago −11.52%α −13.87% · $20.66
  4. T+20 · 6mo ago −8.05%α −13.34% · $21.47
  5. T+60 · 4mo ago +21.71%α +18.64% · $28.42
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Two insiders sold a total of $239K in ARQT shares, representing only 0.008% of market cap. This is trivial and routine activity with no material signal.

Key Financial Metrics

Direction
selling
Total Value
$239.0K
Insiders
2

Key Facts

  • Director Howard G. Welgus sold 7,144 shares ($164K) on 2026-05-01
  • Todd Watanabe (See Remarks) sold 3,172 shares ($75K) on 2026-05-04
  • Total insider sales of $239K are 0.008% of ARQT's $2.9B market cap
  • No insider purchases were made in the cluster period

Financial Impact

Insider sales of $239K are negligible relative to market cap

insider holdings

Risk Factors

  • Insider selling could increase in future periods, but current activity is trivial
  • No identifiable catalyst from the filings provided

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ARQT-1778105196590

Track record

34 reports on ARQT

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +21.34% at T+60 after the Aug 5, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago Press Release Neutral 4/10 Entry $28.26 Now $27.15 −3.93% settles Feb 11
  2. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $27.39 Now $27.15 −0.86% settles Feb 8
  3. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $25.55 Now $27.15 +6.26% settles Feb 4
  4. Nov 4, 202612d ago 3/A / CLUSTER / 3 Neutral 2/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  5. Nov 4, 202612d ago 144 Neutral 3/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  6. Nov 4, 202612d ago 424B5 Bearish 4/10 Entry $27.00 Now $27.15 −0.56% settles Feb 3
  7. Nov 4, 202612d ago 8-K Neutral 5/10 No price data
  8. Nov 4, 202612d ago Press Release Mixed 6/10 Entry $27.00 Now $27.15 +0.56% settles Feb 3
  9. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
  10. Nov 2, 202614d ago 144 Neutral 2/10 Entry $32.00 Now $27.15 −15.16% settles Feb 1
Showing 10 of 34

US Market Status

Market Closed · Opens Wed (10h 45m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published May 6, 2026